HROW |
HARROW, INC. |
Jun 14, 2024 |
1 |
$0 |
4 |
Jun 17, 2024 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Mar 11, 2024 |
3 |
$0 |
4 |
Mar 11, 2024 |
Director |
HROW |
HARROW, INC. |
Jan 26, 2024 |
1 |
$0 |
4 |
Jan 30, 2024 |
Director |
HROW |
HARROW, INC. |
Jan 26, 2024 |
0 |
$0 |
3 |
Jan 30, 2024 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Nov 27, 2023 |
1 |
$0 |
4 |
Nov 28, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Jun 22, 2023 |
1 |
$0 |
4 |
Jun 23, 2023 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Sep 15, 2022 |
1 |
$0 |
4 |
Sep 19, 2022 |
Director |
HARP |
Harpoon Therapeutics, Inc. |
Sep 15, 2022 |
0 |
$0 |
3 |
Sep 19, 2022 |
Director |
EOLS |
Evolus, Inc. |
May 17, 2022 |
2 |
-$871K |
4 |
May 18, 2022 |
Chief Financial Officer and Executive Vice President, Corporate Development |
EOLS |
Evolus, Inc. |
Mar 8, 2022 |
1 |
-$99.1K |
4 |
Mar 10, 2022 |
Chief Financial Officer and Executive Vice President, Corporate Development |
EOLS |
Evolus, Inc. |
Jan 24, 2022 |
2 |
$0 |
4 |
Jan 26, 2022 |
Chief Financial Officer and Executive Vice President, Corporate Development |
EOLS |
Evolus, Inc. |
Aug 10, 2021 |
1 |
-$160K |
4/A |
Aug 12, 2021 |
Chief Financial Officer and Executive Vice President, Corporate Development |